Recent studies have reported that YKL-39 has monocyte chemotactic and pro-angiogenic activity and is expressed in M2 macrophages from breast, glioma, and kidney cancers, and affects tumor angiogenesis; overexpressed YKL-39 is associated with poor prognosis [20–22]. The gene discussed is CHI3L2; the disease is central nervous system cancer.